Purchase Order HHSN272201800186P
- Not listed
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC for the provision of COVID-19 TURBO 293 transfection reagents. The contract, valued at $148,325.00, has a period of performance through June 8, 2023. Speed Biosystems is a minority-owned, small disadvantaged business that has previously received over $3 million in prime federal contracts...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,788.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract has a...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a small disadvantaged business, for the provision of 50 units of the company's TURBO293 transfection reagent at a total value of $148,325. The contract supports COVID-19 research at the Vaccine Research Center within NIAID. The requirement was sole-sourced to Speed Biosystems as the proprietary developer of the...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $123,192.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. This sole-source award was made under the...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents. The $248,980.00 contract supports coronavirus-related research at NIH labs and the Vaccine Research Center. The award was sole-sourced to Speed Biosystems as the proprietary developer of...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, to provide 70 units of TURBO293 transfection reagent at a potential value of $146,750.00. The contract supports COVID-19 research and vaccine production activities at NIH labs in Maryland. This sole-source award was made under the...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small disadvantaged business, for the provision of TURBO293 transfection reagents to support coronavirus-related research. The contract, valued at $148,325.00, does not have a set-aside designation. Speed Biosystems has received over $3 million in prime federal contracts from...
- The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Speed Biosystems, LLC, a self-certified small disadvantaged and minority-owned business. The $146,600.00 contract is for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The contract does...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $146,750.00 firm fixed price purchase order contract to Speed Biosystems, LLC, a minority-owned small business, for the provision of 70 units of TURBO293 Transfection Reagent (20ML). This sole-source award was made on a non-competed basis under the authority of FAR 13.106-1 for only one responsible source, as Speed Biosystems is the...
- This is a sole-source purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,860.00 firm-fixed-price contract is for the delivery of 46 units of TURBO293 Transfection Reagents, a specialized biological product used in coronavirus-related research, vaccine production, and immunogen development. The contract supports critical...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Speed Biosystems, LLC, a minority-owned, small disadvantaged business, for the provision of TURBO293 transfection reagents, kits, protocols, and continuity support to aid coronavirus-related research at NIH labs and the Vaccine Research Center. The $146,600.00 contract was sole-sourced to Speed Biosystems as the proprietary developer of the TURBO293 reagents, with delivery taking place at locations in Bethesda and Rockville, Maryland over a performance period of approximately 4-12 months. The contract did not involve any set-asides or subcontractors.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Turbo 293 Transfection Reagent | RFQ-NIAID-B-1875995 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 11/7/17, 10:55 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $146.6k | 11/29/17 |